Mark A. Goldsmith - Dec 18, 2024 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Role
President and Chief Executive Officer, Director
Signature
/s/ Jack Anders, as attorney-in fact for Mark A. Goldsmith
Stock symbol
RVMD
Transactions as of
Dec 18, 2024
Transactions value $
$15,115
Form type
4
Date filed
12/20/2024, 04:50 PM
Previous filing
Dec 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVMD Common Stock Options Exercise $15.1K +30.8K +9.49% $0.49 356K Dec 18, 2024 Direct F1
holding RVMD Common Stock 20.4K Dec 18, 2024 Trust F2
holding RVMD Common Stock 20.4K Dec 18, 2024 Trust F3
holding RVMD Common Stock 466K Dec 18, 2024 Trust F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RVMD Stock Option (Right to Buy) Options Exercise $0 -30.8K -100% $0.00 0 Dec 18, 2024 Common Stock 30.8K $0.49 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 167,125 restricted stock units.
F2 Held by Jonathan Goldsmith Revocable Trust.
F3 Held by Rebecca Eve Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
F4 Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.

Remarks:

President and Chief Executive Officer